Critical Care

official impact factor 4.60

Open Access

The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation

Nalan Kayhan, Benjamin Funke, Lars O Conzelmann, Harald Winkler, Stefan Hofer, Jochen Steppan, Heinfried Schmidt, Hubert Bardenheuer, Christian-Friedrich Vahl and Markus A Weigand*

Critical Care 2008, 12:R125 doi:10.1186/cc7033

Accesses  

  • Last 30 days: 75 accesses
  • Last 365 days: 700 accesses
  • All time: 3321 accesses